Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 17 Hydroxy 3 Oxo 17alpha Pregna 4,6 Diene 21 Carboxylic Acid
2. 17-hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic Acid
3. Acid, 17-hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylic
4. Acid, Canrenoic
5. Canrenoate Potassium
6. Canrenoate, Potassium
7. Canrenoic Acid
8. Kalium Can. Ratiopharm
9. Kalium-can.-ratiopharm
10. Sc 14266
11. Sc-14266
12. Sc14266
13. Soldactone
14. Soludactone
15. Spiroctan
1. Canrenoic Acid Potassium Salt
2. Canrenoate Potassium
3. Soldactone
4. 2181-04-6
5. Kanrenol
6. Canrenoate (potassium)
7. Canrenoic Acid Potassium
8. Potassium Aldadiene
9. Potassium Canrenoate [inn]
10. M671f9nlea
11. Canrenoate Potassium [usan]
12. Sc-14266
13. Mls002154212
14. Canrenone Free Acid Potassium Salt
15. Nsc-757789
16. Canrenoate Potassium (usan)
17. Soludactone
18. Apiroctan
19. Venactone
20. Kalii Canrenoas
21. Aldadiene-kalium
22. Kalium Canrenoat
23. Soldactone (tn)
24. Aldadiene-potassium
25. Canrenoato Potasico
26. Ncgc00017146-01
27. Prestwick_910
28. Canrenoate De Potassium
29. Aldadiene Potassium Salt
30. Aldadiene-kalium [german]
31. Unii-m671f9nlea
32. Dsstox_cid_25602
33. Dsstox_rid_80995
34. Dsstox_gsid_45602
35. Schembl49729
36. Kalii Canrenoas [inn-latin]
37. Potassium Canrenoate (jp17)
38. Mf 465a
39. Ccris 9164
40. Chembl1371200
41. Dtxsid2045602
42. Hy-b1582a
43. Canrenoato Potasico [inn-spanish]
44. Hms1568m18
45. Hms2095m18
46. Hms2235n14
47. Hms3712m18
48. Potassium Canrenoate [jan]
49. Einecs 218-554-9
50. Tox21_110800
51. Potassium Canrenoate [mart.]
52. Canrenoate De Potassium [inn-french]
53. Potassium Canrenoate [who-dd]
54. Akos025402245
55. Ac-6875
56. Cb 8109
57. Ccg-220148
58. Nsc 757789
59. Sc 14266
60. Smr001233495
61. Cas-2181-04-6
62. Cs-0013479
63. Canrenone Free Acid Potassium Salt [mi]
64. D01943
65. Q3655600
66. W-107518
67. Potassium 17-hydroxy-3-oxo-17-alpha-pregna-4,6-diene-21-carboxylate
68. Potassium 17-hydroxy-3-oxo-17alpha-pregna-4,6-diene-21-carboxylate
69. Potassium 3-(17-beta-hydroxy-3-oxoandrosta-4,6-dien-17-yl)propionate
70. 17-alpha-pregna-4,6-diene-21-carboxylic Acid, 17-hydroxy-3-oxo-, Monopotassium Salt
71. Potassium 17-hydroxy-3-oxo-17.alpha.-pregna-4,6-diene-21-carboxylate
72. Potassium 3-(3-oxo-17-beta-hydroxy-4,6-androstadien-17-alpha-yl)propanoate
73. Pregna-4,6-diene-21-carboxylic Acid, 17-hydroxy-3-oxo-, Monopotassium Salt (17alpha)-
74. Pregna-4,6-diene-21-carboxylic Acid, 17-hydroxy-3-oxo-, Monopotassium Salt (17.alpha.)-
Molecular Weight | 396.6 g/mol |
---|---|
Molecular Formula | C22H29KO4 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 396.17029089 g/mol |
Monoisotopic Mass | 396.17029089 g/mol |
Topological Polar Surface Area | 77.4 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 713 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Mineralocorticoid Receptor Antagonists
Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE. (See all compounds classified as Mineralocorticoid Receptor Antagonists.)
C - Cardiovascular system
C03 - Diuretics
C03D - Aldosterone antagonists and other potassium-sparing agents
C03DA - Aldosterone antagonists
C03DA02 - Potassium canrenoate
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Global Sales Information
ANALYTICAL
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?